The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Micrus Endovascular Corp.  (MEND) Trade Now »     Rate MEND  -  Discuss MEND  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Medical Equipment & Supplies
This is a micro-cap stock and may be a target of manipulation. Always do your research!

SocialPicks Sentiment:
N/A

** not enough data to be rated
This Quarter's Sentiment:
All:
87.5%
Top:
0.0%
Rate MEND:



MEND Analysis & Videos »


MEND: Bull or Bear?

Micrus Endovascular Corp. Graphic_rating_buy MEND
Foto
62%
By  Marian Filo   (-24.55%  risk: aggressive)  05/22/09 5 comments


Micrus Endovascular Corp. Graphic_rating_sell MEND
Foto
62%
By  Marian Filo   (-24.55%  risk: aggressive)  05/08/09 1 comment


Appropriate Value for Micrus Endo MEND
By  Zacks.com   (-1.03%  risk: moderate)  06/18/08 1 comment


Get free stock alert for MEND:
Your Email Address:


Bottom Fishing Graphic_rating_buy MEND
Barbaro
69%
By  dogcrap   (+22.08%  risk: aggressive)  09/19/07 4 comments





People Bullish on MEND

Foto
Marian Filo
Principal
62%
over 4 years ago

latresca
Analyst
30%
over 6 years ago

petrsedivec
Analyst
29%
over 6 years ago


People Bearish on MEND

ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +32.13% 538
2 18.14 +6.82% 289
3 17.66 +22.47% 85
4 13.47 +13.86% 71
5 12.13 +175.56% 106


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on MEND


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About Micrus Endovascular Corp. - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch